Novel triphenylphosphonium-hydrazone salts: integrated experimental and computational insights into AChE inhibition and resistance-overcoming antimicrobial and antibiofilm potential
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-03 · 399 (6) · 9189-9201
DOI: 10.1007/s00210-026-05002-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 20.01.2026. Verfasst von Metin Yıldırım und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Harran University, Sanliurfa, Türkiye. metinyildirim4@gmail.com. Hauptthemen laut MEDLINE: Biofilms, Cholinesterase Inhibitors, Hydrazones, Anti-Bacterial Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Harran University.
Abstract (Originalsprache)
Neurodegenerative disorders and multidrug-resistant (MDR) bacterial infections represent two major and interconnected global health challenges. However, current therapeutic strategies are largely limited by single-target approaches, insufficient efficacy against biofilm-forming MDR pathogens, and the lack of multifunctional small molecules capable of addressing both neurodegeneration and bacterial resistance simultaneously. These limitations constitute a critical technical bottleneck in contemporary drug discovery and underscore the urgent need for innovative, dual-action therapeutic scaffolds. In this study, five novel triphenylphosphonium–hydrazone derivatives (1a–1e) were rationally designed, synthesized, and fully characterized by FT-IR, 1H/13C NMR, and HR-MS/MS analyses to overcome these challenges by integrating neuroprotective and antimicrobial functionalities within a single molecular framework. All synthesized compounds exhibited potent acetylcholinesterase (AChE) inhibitory activity, with IC₅₀ values ranging from 8.66 to 13.9 µM, highlighting their strong neuroactive profiles. Notably, compound 1b emerged as the most effective AChE inhibitor (IC₅₀ = 8.66 µM), underscoring its promise as a lead scaffold for the development of next-generation anti-Alzheimer agents. Beyond enzyme inhibition, the compounds demonstrated significant antibacterial efficacy against clinically relevant carbapenem-resistant pathogens. In particular, compound 1d showed the strongest activity against Acinetobacter baumannii and Klebsiella pneumoniae , with MIC values of 32 µg/mL and 64 µg/mL, respectively. Importantly, all derivatives (1a–1e) exhibited dose-dependent antibiofilm activity, achieving up to 83.4% biofilm disruption in Acinetobacter baumannii and 72.8% in Escherichia coli at 1024 µg/mL, directly addressing a major resistance-associated bottleneck in antibacterial therapy. Molecular docking studies provided mechanistic validation of this multifunctional design, revealing a strong binding affinity of compound 1d toward PBP1A (PDB: 6OWS) and the AcrB efflux pump protein (PDB: 6PT1), suggesting a previously unexplored dual antibacterial mechanism involving simultaneous inhibition of cell-wall biosynthesis and efflux-mediated drug resistance. Overall, this study introduces a novel triphenylphosphonium–hydrazone platform, establishes a clear structure–activity relationship, and highlights its potential as a multifunctional therapeutic strategy against both neurodegenerative disorders and MDR bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Harran University, Sanliurfa, Türkiye. metinyildirim4@gmail.com.
- Department of Chemistry, Faculty of Science, Eskisehir Technical University, Eskisehir, Türkiye.
- Department of Pharmacy Services, Vocational School of Health Services, Harran University, Sanliurfa, Türkiye.
- Faculty of Pharmacy, Harran University, Sanliurfa, Türkiye.
- Department of Chemistry, Faculty of Art and Science, Cukurova University, Adana, 01330, Türkiye.
Förderung
- Harran University
Zitieren
APA
Yıldırım, M., Ünver, H., Necip, A., Hord, B., & Ersatir, M. (2026). Novel triphenylphosphonium-hydrazone salts: integrated experimental and computational insights into AChE inhibition and resistance-overcoming antimicrobial and antibiofilm potential. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(6), 9189-9201. https://doi.org/10.1007/s00210-026-05002-8
Vancouver
Yıldırım M, Ünver H, Necip A, Hord B, Ersatir M. Novel triphenylphosphonium-hydrazone salts: integrated experimental and computational insights into AChE inhibition and resistance-overcoming antimicrobial and antibiofilm potential. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(6):9189-9201. doi:10.1007/s00210-026-05002-8
BibTeX
@article{Yldrm2026,
author = {Yıldırım, Metin and Ünver, Hakan and Necip, Adem and Hord, Büsra and Ersatir, Mehmet},
title = {Novel triphenylphosphonium-hydrazone salts: integrated experimental and computational insights into AChE inhibition and resistance-overcoming antimicrobial and antibiofilm potential},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {6},
pages = {9189--9201},
doi = {10.1007/s00210-026-05002-8}
}
EUVIMED